Patient Advocate Reed Defends Patient Advocates on Stem Cell Board
Patient advocate Don Reed, declaring that the Institute of Medicine's (IOM) 17-month study of the $3 billion California stem cell agency is "grossly misguided," this weekend nonetheless said the agency took "the high road" in its response to the study's recommendation.
Reed, of Fremont, Ca., was particularly incensed about the IOM's recommendations conce…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.